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ABSTRACT 
Dapsone (DDS – Diamino diphenyl sulfone), a sulfonamide derivative acts by inhibiting PABA incorporation into folic acid. It 
is commonly used in treating skin diseases. Accidental poisoning in children is uncommon. It results in methaemoglobinemia 
by causing oxidative stress. Principle of treatment relies on treating methemoglobinemia by using reducing agents like 
methylene blue or ascorbic acid. Due to the long half-life, dapsone provides a continuing oxidative stress that can cause a 
recurrence of clinically significant methaemoglobinaemia and hence takes long to treat. Ascorbic acid is effective in treating 
methemoglobinemia associated with dapsone poisoning as demonstrated in this case report of a four and half year old child’s 
accidental ingestion of dapsone tablets and presenting with cyanosis. The child was managed successfully with ascorbic acid 
and supportive treatment. 
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apsone (DDS – Diamino diphenyl sulfone), a 
sulfonamide derivative acts by inhibiting Para 
Amino Benzoic Acid (PABA) incorporation into 
folic acid. Although, it is traditionally an antileprosy drug, 
the use of dapsone has expanded into the treatment of 
dermatologic conditions, including pyoderma 
gangrenosum and dermatitis herpetiformis. Dapsone has 
several off-label uses such as treatment of Pneumocystis 
jiroveci pneumonia, bullous systemic lupus erythematosus, 
and severe aphthous ulcers [1].  
Accidental dapsone poisoning during childhood is 
uncommon [2,3]. There is paucity of literature regarding 
the incidence of dapsone-induced methemoglobinemia in 
children. However, in hematopoietic stem cell transplant 
recipients receiving dapsone for Pseudomonas jiroveci 
pneumonia prophylaxis, the incidence is approximately 
3% [4]. 
 
CASE REPORT 
A four and half year-old male child presented to Pediatric 
department emergency with irritability, restlessness and 
difficulty in breathing which started immediately after 
waking up in morning. There was history of accidental 
ingestion of 4 dapsone tablets (100 mg each) around 12 
hours back. The drug was being taken by his mother for 
the treatment of lichen planus. There was no history of 
fever, cough, or chest pain, or any history suggestive of 
foreign body inhalation. There was no history of asthmatic 
episodes in past or in family. 
Examination of the child at the time of presentation 
revealed central cyanosis, pulse rate of 108/min, regular 
rhythm and normal volume, respiratory rate was 36/min 
with nasal flaring, normal body temperature and blood 
pressure was 100/60 mm-Hg. SPo2 was 82% on room air 
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which increased to only 85% with oxygen (4 L/min). The 
respiratory system was normal on examination and rest 
other systems were also normal. 
Arterial and venous blood drawn for investigations 
was chocolate brown in colour. His routine laboratory 
investigations including hemoglobin (10.5 g/dl) and total 
leukocyte count (7400/mm3), blood urea and creatinine 
and serum electrolytes were within normal limits. Arterial 
blood gas analysis was within normal limits (pH - 7.49, 
PCO2 - 26.4, PO2 - 103, HCO3 - 19.9 and O2 saturation - 
98.5%). However, the methemoglobin level was 
significantly elevated (19%).  
The child was started on supportive treatment. Gastric 
lavage was done and child was kept under oxygen by nasal 
prongs. As, injection methylene blue was unavailable and 
patient’s G6PD status was not known [5], treatment was 
initiated by intravenous injection of ascorbic acid 500 mg 
at admission. Injection ascorbic acid was continued on 
next day at same dose and then the child was started on 
oral ascorbic acid, once he showed signs of improvement. 
Patient remained cyanosed till 4th day of admission after 
which his saturation returned to normal. His 
methemoglobin level was decreased to 2% on day 7 of 
admission. The patient was discharged successfully and 
was doing well on one and two months follow-up. 
DISCUSSION 
Accidental dapsone poisoning is a pediatric emergency in 
young preschool children [6]. Dapsone, a sulfone, is a 
structural analog of paraaminobenzoic acid (PABA) and a 
competitive inhibitor of dihydropteroate synthase in the 
folate pathway. After oral administration, absorption is 
complete; the elimination t½ is 20-30 hours. It undergoes 
N – acetylation by N-Acetyltransferase 2 (NAT2). 
Dapsone hydroxylamine enters red cells leading to 
methemoglobin formation. Sulfones tend to be retained for 
up to 3 weeks in skin and muscle and especially in liver 
and kidney. Intestinal reabsorbtion of sulfones excreted in 
bile lead to long term effects. 
The most frequent reaction to occur with dapsone 
toxicity is hemolytic anemia and methemoglobinemia. 
Hemoglobin levels can decrease by 1–2 g/dL with an 
increase of 2–12% in the reticulocyte count [7]. The 
clinical symptoms of methemoglobinemia vary and depend 
on the methemoglobin concentration in the blood. 
Cyanosis occurs at around 15% methemoglobin 
concentration, and tissue hypoxia can occur as levels raise 
further–methemoglobin levels of 70% or higher can be 
fatal [8]. Methemoglobin is incapable of binding oxygen 
and also increases the affinity of the unaltered hemoglobin 
for oxygen, shifting the oxygen dissociation curve to the 
left; thus, further impairing oxygen delivery resulting in 
difficulty in breathing and low saturation. The CNS 
manifestations like irritability, hypotonia, truncal ataxia, 
choreiform movements, dysarthritic speech and cerebellar 
signs also occur in children with dapsone poisoning. 
Cerebral anoxia due to methemoglobinemia has been 
attributed as the main cause for CNS manifestations [9]. 
In acute dapsone toxicity, initial attempts should be 
directed towards gut decontamination (gastric lavage, 
activated charcoal orally) and improvement of oxygen 
delivery. To improve oxygen delivery, main emphasis is 
on administration of reducing agents such as methylene 
blue and ascorbic acid. Methylene blue is reduced to 
leukomethylene blue by flavin reductase, accepting 
electrons from Nicotinamide Adenine Dinucleotide 
Phosphate (NADPH). Leukomethylene blue acts as an 
electron donor to reduce methemoglobin to hemoglobin, 
converting back to methylene blue in a cyclical redox 
reaction. Conversely, because methylene blue is an 
oxidizing agent, it can itself cause methemoglobinemia by 
oxidizing hemoglobin at high concentrations. It is the 
mainstay of treatment in severe methemoglobinemia.  
Ascorbic acid is a strong reducing agent that takes part 
in many oxidation–reduction reactions. Ascorbic acid 
might be fructuous where methylene blue is not available 
or is contradicted due to deficiency or absence of glucose-
6-phosphate dehydrogenase enzymes [10,11]. Ascorbic 
acid 200-500 mg can be given intravenously, as was 
successfully used in the present case. Exchange transfusion 
had been tried in case not responding to methyleneblue 
[12].  
Patients with dapsone-induced methemoglobinemia 
require serial measurements of methemoglobin levels 
following treatment in order to evaluate the subsequent 
worsening and the need for additional treatment. Routine 
pulse oximetry is generally inaccurate for monitoring 
oxygen saturation in the presence of methemoglobinemia 
as a saturation gap exists [13]. It is suggested that cases 
previously perfectly normal and presenting with 
unexplained central cyanosis with history of ingestion of 
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dapsone be considered as having methemoglobinemia. 
Dapsone, a commonly used drug in the treatment of 
leprosy should be kept out of reach of children to prevent 
significant morbidity and mortality. 
CONCLUSION 
Dapsone poisoning results in methemoglobinemia which 
can be life threatening if not attended promptly. Ascorbic 
acid can be used effectively for the treatment of 
methemoglobinemia. It is suggested that dapsone should 
be kept out of reach of children and in cases of accidental 
ingestion, prompt management has to be done. 
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